Clal Biotechnology Industries Ltd Financial Flexibility Index
Clal Biotechnology Industries Ltd financial flexibility index. Clal Biotechnology Industries Ltd (CBI) has a Financial Flexibility Index of -0.05x as of June 2025. Free cash flow of ILA-1.06 Million (operating CF ILA-1.06 Million minus capex ILA0.00) represents 0% of total liabilities (ILA19.52 Million). See CBI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Clal Biotechnology Industries Ltd (2006–2024)
Financial flexibility index of Clal Biotechnology Industries Ltd from 2006 to 2024. Historical Financial Flexibility Index trend for Clal Biotechnology Industries Ltd across 19 annual periods. Check Clal Biotechnology Industries Ltd (CBI) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Clal Biotechnology Industries Ltd Financial Flexibility Index by Year (2006–2024)
Clal Biotechnology Industries Ltd financial flexibility index by year from 2006 to 2024. Year-by-year free cash flow to debt coverage for Clal Biotechnology Industries Ltd. For the full cash flow conversion analysis, see Clal Biotechnology Industries Ltd (CBI) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.30x | ILA-6.48 Million | ILA-6.48 Million | ILA21.52 Million | ▼ -30.8% |
| 2023 | -0.23x | ILA-8.51 Million | ILA-8.51 Million | ILA36.98 Million | ▲ +84.9% |
| 2022 | -1.53x | ILA-57.76 Million | ILA-59.04 Million | ILA37.79 Million | ▼ -309.9% |
| 2021 | -0.37x | ILA-39.73 Million | ILA-41.33 Million | ILA106.55 Million | ▼ -24.4% |
| 2020 | -0.30x | ILA-30.04 Million | ILA-33.23 Million | ILA100.24 Million | ▼ -219.6% |
| 2019 | 0.25x | ILA29.86 Million | ILA27.03 Million | ILA119.12 Million | ▲ +144.3% |
| 2018 | -0.57x | ILA-84.03 Million | ILA-86.98 Million | ILA148.46 Million | ▼ -47.6% |
| 2017 | -0.38x | ILA-86.72 Million | ILA-91.41 Million | ILA226.14 Million | ▼ -30.5% |
| 2016 | -0.29x | ILA-107.65 Million | ILA-112.63 Million | ILA366.21 Million | ▲ +4.8% |
| 2015 | -0.31x | ILA-135.94 Million | ILA-147.00 Million | ILA440.31 Million | ▼ -15.9% |
| 2014 | -0.27x | ILA-114.14 Million | ILA-115.95 Million | ILA428.44 Million | ▲ +2.2% |
| 2013 | -0.27x | ILA-147.25 Million | ILA-148.98 Million | ILA540.45 Million | ▼ -21.8% |
| 2012 | -0.22x | ILA-79.22 Million | ILA-81.22 Million | ILA354.19 Million | ▲ +68.8% |
| 2011 | -0.72x | ILA-101.82 Million | ILA-102.45 Million | ILA142.01 Million | ▲ +7.4% |
| 2010 | -0.77x | ILA-107.00 Million | ILA-111.93 Million | ILA138.20 Million | ▼ -54.0% |
| 2009 | -0.50x | ILA-77.13 Million | ILA-86.86 Million | ILA153.41 Million | ▼ -49.3% |
| 2008 | -0.34x | ILA-50.99 Million | ILA-52.41 Million | ILA151.47 Million | ▲ +17.8% |
| 2007 | -0.41x | ILA-45.45 Million | ILA-47.05 Million | ILA110.98 Million | ▲ +77.4% |
| 2006 | -1.81x | ILA-22.67 Million | ILA-23.55 Million | ILA12.50 Million | — |